KORRO BIO INC. - COMMON STOCK

37.30

24-January-25 16:45:00

15 minutes delayed

Stocks

-0.66

-1.74%

Today's range

37.25 - 38.91

ISIN

N/A

Source

NASDAQ

Korro to Present at the TD Cowen 44th Annual Health Care Conference

27 Feb 2024 08:00:01 By Nasdaq GlobeNewswire
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

18 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference

04 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

07 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.